- Home
- FTI vs BAX Comparison
FTI vs BAX Comparison
Compare FTI & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTI | BAX |
|---|---|---|
| Founded | 1884 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.6B | 9.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FTI | BAX |
|---|---|---|
| Price | $46.11 | $18.54 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $45.60 | $25.67 |
| AVG Volume (30 Days) | 2.7M | ★ 8.3M |
| Earning Date | 10-23-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.43% | 0.22% |
| EPS Growth | ★ 59.09 | N/A |
| EPS | ★ 2.28 | N/A |
| Revenue | $9,803,000,000.00 | ★ $11,023,000,000.00 |
| Revenue This Year | $10.34 | $5.20 |
| Revenue Next Year | $7.23 | $2.02 |
| P/E Ratio | $20.18 | ★ N/A |
| Revenue Growth | ★ 11.44 | 3.90 |
| 52 Week Low | $22.12 | $17.40 |
| 52 Week High | $47.33 | $37.74 |
Technical Indicators
Market Signals| Indicator | FTI | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 67.50 | 43.20 |
| Support Level | $44.93 | $18.33 |
| Resistance Level | $47.33 | $19.17 |
| Average True Range (ATR) | 1.18 | 0.54 |
| MACD | 0.05 | 0.21 |
| Stochastic Oscillator | 74.85 | 63.23 |
Price Performance
Historical ComparisonAbout FTI TechnipFMC plc
TechnipFMC is the largest provider of offshore oilfield services, offering integrated deep-water offshore oil and gas development solutions that span the full spectrum of subsea equipment and subsea construction services. The company also provides various pieces of surface equipment used with onshore oil and gas wells. TechnipFMC originated with the 2017 merger of Technip and FMC Technologies.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.